| Income Statement | 2025-07-31 | 2024-10-31 | 2024-07-31 | |
|---|---|---|---|---|
| Net income (loss) attributable to common stockholders | -8,360,096 | -2,958,875 | 20,587,507 | |
| Basic income (loss) per share attributable to common stockholders | -1.23 | -0.39 | 1.9 | |
| Diluted income (loss) per share attributable to common stockholders | -1.23 | -0.39 | 1.9 | |
| Weighted average shares outstanding basic | 6,795,779 | 7,637,034 | 7,866,387 | |
| Weighted average shares outstanding diluted | 6,795,779 | 7,637,034 | 7,866,387 | |
PharmaCyte Biotech, Inc. (PMCB)
PharmaCyte Biotech, Inc. (PMCB)